Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
about
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.Osteopontin at the Crossroads of Inflammation and Tumor Progression.Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer.Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies.
P2860
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@ast
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@en
type
label
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@ast
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@en
prefLabel
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@ast
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@en
P2093
P2860
P356
P1476
Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity
@en
P2093
Huafeng Wei
Huajing Wang
Rongjie Jia
P2860
P356
10.1038/CDDIS.2016.422
P50
P577
2016-12-29T00:00:00Z